Coagulation pathways in atherothrombosis

Trends in Cardiovascular Medicine

Volumn 12, Issue 7, 2002, Pages 317-324

  Khrenov, Alexey V ^a   Ananyeva, Natalya M ^a   Griffin, John H ^b   Saenko, Evgueni L ^a  

^a HOLLAND LABORATORY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CAUSE OF DEATH; FIBRINOLYSIS; GENE EXPRESSION; HEART INFARCTION; HUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOGENESIS; THROMBOSIS;

ANIMALS; ARTERIOSCLEROSIS; BLOOD COAGULATION; HUMANS; THROMBOSIS;

EID: 0036811133     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00182-2     Document Type: Review

References (60)

1. Ananyeva N., Kouiavskaia D., Shima M., Saenko E. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood. 99:2002;4475-4485.
2. Ardissino D., Merlini P.A., Ariens R.et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet. 349:1997;769-771.
3. Bachem M.G., Wendelin D., Schneiderhan W.et al. Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells. Clin Chem Lab Med. 37:1999;319-326.
4. Badimon J.J., Fuster V., Chesebro J.H., Badimon L. Coronary atherosclerosis. A multifactorial disease. Circulation. 87:1993;II3-II16.
5. Badimon J.J., Lettino M., Toschi V.et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques. effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions Circulation. 99:1999;1780-1787.
6. Bernard G.R., Vincent J.L., Laterre P.F.et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 344:2001;699-709.
7. Bilora F., Boccioletti V., Zanon E.et al. Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries. factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis Clin Appl Thromb Haemostasis. 7:2001;311-313.
8. Bjorkerud S., Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 149:1996;367-380.
9. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429-2442.
10. Brand K., Banka C.L., Mackman N.et al. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb. 14:1994;790-797.
11. Brinkman H.J.M., Mertens K., Holthuis J.et al. The activation of human blood coagulation factor X on the surface of endothelial cells. a comparison with various vascular cells, platelets and monocytes Br J Haematol. 87:1999;332-342.
12. Caplice N.M., Panetta C., Peterson T.E.et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor. a novel link between lipoproteins and thrombosis Blood. 98:2001;2980-2987.
13. Crawley J., Lupu F., Westmuckett A.D.et al. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol. 20:2000;1362-1373.
14. Cyrus T., Pratico D., Zhao L.et al. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 103:2001;2277-2282.
15. Deguchi H., Fernandez J.A., Griffin J.H. Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S. J Biol Chem. 277:2002;8861-8865.
16. Deguchi H., Fernandez J.A., Pabinger I.et al. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood. 97:2001;1907-1914.
17. Esmon C.T. Regulation of blood coagulation. Biochim Biophys Acta. 1477:2000;349-360.
18. Fei H., Berliner J.A., Parhami F., Drake T.A. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb. 13:1993;1711-1717.
19. Fernandez J.A., Kojima K., Petaja J.et al. Cardiolipin enhances protein C pathway anticoagulant activity. Blood Cells Mol Dis. 26:2000;115-123.
20. Gilbert G.E., Arena A.A. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem. 271:1996;11,120-11,125.
21. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead Cell. 104:2001;503-516.
22. Griffin J.H., Kojima K., Banka C.L.et al. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest. 103:1999;219-227.
23. Hamik A., Setiadi H., Bu G.et al. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J Biol Chem. 274:1999;4962-4969.
24. Handschug K., Schulz S., Schnurer C.et al. Low-density lipoprotein receptor-related protein in atherosclerosis development. up-regulation of gene expression in patients with coronary obstruction J Mol Med. 76:1998;596-600.
25. Hasenstab D., Lea H., Hart C.E.et al. Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation. 101:2000;2651-2657.
26. Herz J., Strickland D.K. Lrp. a multifunctional scavenger and signaling receptor J Clin Invest. 108:2001;779-784.
27. Ishibashi S. Lipoprotein(a) and atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1-2.
28. Khrenov A., Sarafanov A., Ananyeva N.et al. Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex. Thromb Res. 105:2002;87-93.
29. Laszik Z., Carson C.W., Nadasdy T.et al. Lack of suppressed renal thrombomodulin expression in a septic rat model with glomerular thrombotic microangiopathy. Lab Invest. 70:1994;862-867.
30. Li W., Yuan X.M., Olsson A.G., Brunk U.T. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol. 18:1998;177-184.
31. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 104:2001;365-372.
32. Mallat Z., Hugel B., Ohan J.et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. a role for apoptosis in plaque thrombogenicity Circulation. 99:1999;348-353.
33. Mann K.G. Biochemistry and physiology of blood coagulation. Thromb Haemostasis. 82:1999;165-174.
34. Mertens A., Holvoet P. Oxidized LDL and HDL. antagonists in atherothrombosis FASEB J. 15:2001;2073-2084.
35. Moreno P.R., Bernardi V.H., Lopez-Cuellar J.et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090-3097.
36. Moyer M.P., Tracy R.P., Tracy P.B.et al. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vasc Biol. 18:1998;458-465.
37. Neels J.G., Bovenschen N., Zonneveld A.-J., Lenting P. Interaction between factor VIII and LDL receptor-related protein. Trends Cardiovasc Med. 10:2000;8-14.
38. Okura Y., Brink M., Itabe H.et al. Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation. 102:2000;2680-2686.
39. Ovanesov MV, Lopatina EG, Saenko EL, et al.: 2002. Effect of Factor III on Tissue Factor-activated Spatial Clot Growth. Unpublished manuscript.
40. Pan W.-H., Bai C.-H., Chen J.-R., Chiu H.-C. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke. 28:1997;88-94.
41. Penn M.S., Cui M.Z., Winokur A.L.et al. Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation. Blood. 96:2000;3056-3063.
42. Rauch U., Osende J.I., Fuster V.et al. Thrombus formation on atherosclerotic plaques. pathogenesis and clinical consequences Ann Intern Med. 134:2001;224-238.
43. Rosendaal F.R. Factor VIII and coronary heart disease. Eur J Epidemiol. 8:1992;71-75.
44. Rosendaal F.R., Briet E., Stibbe J.et al. Haemophilia protects against ischaemic heart disease. a study of risk factors Br J Haematol. 75:1990;525-530.
45. Saenko E.L., Scandella D., Yakhyaev A.V., Greco N. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J Biol Chem. 273:1998;27,918-27,926.
46. Saenko E.L., Shima M., Sarafanov A.G. Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. Trends Cardiovasc Med. 9:1999;185-192.
47. Safa O., Hensley K., Smirnov M.D.et al. Lipid oxidation enhances the function of activated protein C. J Biol Chem. 276:2001;1829-1836.
48. Sata M., Walsh K. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem. 273:1998;33,103-33,106.
49. Schecter A.D., Spirn B., Rossikhina M.et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res. 87:2000;126-132.
50. Schuff-Werner P., Claus G., Armstrong V.W.et al. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis. 78:1989;109-112.
51. Sramek A., Reiber J.H., Gerrits W.B., Rosendaal F.R. Decreased coaguability has no clinically relevant effect on atherogenesis. observations in individuals with a hereditary bleeding tendency Circulation. 104:2001;762-767.
52. Tedgui A., Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemostasis. 86:2001;420-426.
53. Tipping P.G., Malliaros J., Holdsworth S.R. Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis. 79:1989;237-243.
54. Toschi V., Gallo R., Lettino M.et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
55. Triemstra M., Rosendaal F.R., Smit C.et al. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 (to 1992 and 1973 to 1986. Ann Intern Med 123):1995;823-827.
56. Virmani R., Burke A.P., Farb A. Sudden cardiac death. Cardiovasc Pathol. 10:2001;211-218.
57. Weis J.R., Pitas R.E., Wilson B.D., Rodgers G.M. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5:1991;2459-2465.
58. Wilcox J.N., Smith K.M., Schwartz S.M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 86:1989;2839-2843.
59. Wintergerst E.S., Jelk J., Rahner C., Asmis R. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. Eur J Biochem. 267:2000;6050-6059.
60. Xu W., Takahashi Y., Sakashita T.et al. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase. J Biol Chem. 276:2001;36,454-36,459.